Bacteriophage-based antibacterials (iNtRON Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBacteriophage-based antibacterials (iNtRON Biotechnology)
Drug Alias NameBio-drug therapeutics for superbacteria - iNtRON BiotechnologyNPA-200
ClassificationBiologics
Mechanisms of ActionCell wall modulatorsCell membrane modulatorsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntron Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntron Biotechnology
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A